Johnson & Johnson Loses in Court Again in Bid to Settle Talc CasesJudge rejects J&J's $9B talc settlement, citing ongoing litigation and denial of asbestos-linked cancer claims.
UK firm GSK to pay $2.2bn over Zantac cancer claimsGSK is settling $2.2bn over Zantac cancer claims, resolving 93% of lawsuits without admitting wrongdoing.